Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. Semin Intervent Radiol 2013 Mar;30(1):21-7
Date
01/18/2014Pubmed ID
24436514Pubmed Central ID
PMC3700793DOI
10.1055/s-0033-1333650Scopus ID
2-s2.0-84874392025 (requires institutional sign-in at Scopus site) 12 CitationsAbstract
Cholangiocarcinoma, whether arising from the intrahepatic or extrahepatic biliary system, is a rare but devastating malignancy. Prognosis is poor, with 5-year overall survival <5% including patients undergoing surgery. Resection is the only curative treatment; however, only ∼30% of patients present at a resectable stage, and intrahepatic recurrence is common even after complete resection. This article discusses the current role of transarterial therapies in the treatment of intrahepatic cholangiocarcinoma.
